Randomized, Double-Blind Study of Emtricitabine (FTC) plus Clevudine versus FTC Alone in Treatment of Chronic Hepatitis B

Emtricitabine (FTC) is approved for the treatment of human immunodeficiency virus. FTC and clevudine (CLV) have activity against hepatitis B virus (HBV). This report summarizes the results of a double-blind, multicenter study of patients with chronic hepatitis B who had completed a phase 3 study of...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lim, Seng Gee, Krastev, Zahary, Ng, Tay Meng, Mechkov, Grigor, Kotzev, Iskren Andreev, Chan, Sing, Mondou, Elsa, Snow, Andrea, Sorbel, Jeff, Rousseau, Franck
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2006
Témata:
Antiviral Agents
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1472200/
https://ncbi.nlm.nih.gov/pubmed/16641430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.50.5.1642-1648.2006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky